Literature DB >> 17698724

Effects of PREMIER lifestyle modifications on participants with and without the metabolic syndrome.

Lillian F Lien1, Ann J Brown, Jamy D Ard, Catherine Loria, Thomas P Erlinger, Adrianne C Feldstein, Pao-Hwa Lin, Catherine M Champagne, Abby C King, Heather L McGuire, Victor J Stevens, Phillip J Brantley, David W Harsha, Mary Ann McBurnie, Lawrence J Appel, Laura P Svetkey.   

Abstract

Lifestyle modification can reduce blood pressure and lower cardiovascular risk. Established recommendations include weight loss, sodium reduction, and increased physical activity. PREMIER studied the effects of lifestyle interventions based on established recommendations alone and with the addition of the Dietary Approaches to Stop Hypertension (DASH) dietary pattern. This analysis aimed to assess the interventions' impact on cardiometabolic variables in participants with, compared with those without, metabolic syndrome. The primary outcome was 6-month change in systolic blood pressure. Participants with prehypertension or stage-1 hypertension were randomly assigned to an advice only control group, a 6-month intensive behavioral intervention group of established recommendations (EST), or an established recommendations plus DASH group (EST+DASH). Metabolic syndrome was defined per National Cholesterol and Education Program Adult Treatment Panel III. We used general linear models to test intervention effects on change in blood pressure, lipids, and insulin resistance (homeostasis model assessment), in subgroups defined by the presence or absence of metabolic syndrome. Of 796 participants, 399 had metabolic syndrome. Both EST and EST+DASH reduced the primary outcome variable, systolic blood pressure. Within the EST+DASH group, those with and without metabolic syndrome responded similarly (P=0.231). However, within EST, those with metabolic syndrome had a poorer response, with a decrease in systolic blood pressure of 8.4 mm Hg versus 12.0 mm Hg in those without metabolic syndrome (P=0.002). Thus, metabolic syndrome attenuated the systolic blood pressure reduction of EST, but this attenuation was overcome in EST+DASH. Finally, diastolic blood pressure, lipids, and homeostasis model assessment responded similarly to both interventions regardless of metabolic syndrome status. Our data suggest that strategies for lowering BP in individuals with metabolic syndrome may be enhanced by recommendations to adopt the DASH dietary pattern.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17698724     DOI: 10.1161/HYPERTENSIONAHA.107.089458

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  32 in total

Review 1.  Reduced or modified dietary fat for preventing cardiovascular disease.

Authors:  Lee Hooper; Carolyn D Summerbell; Rachel Thompson; Deirdre Sills; Felicia G Roberts; Helen J Moore; George Davey Smith
Journal:  Cochrane Database Syst Rev       Date:  2012-05-16

Review 2.  Contemporary strategies for weight loss and cardiovascular disease risk factor modification.

Authors:  Alison M Hill; Penny M Kris-Etherton
Journal:  Curr Atheroscler Rep       Date:  2008-12       Impact factor: 5.113

Review 3.  The DASH diet and insulin sensitivity.

Authors:  Alan L Hinderliter; Michael A Babyak; Andrew Sherwood; James A Blumenthal
Journal:  Curr Hypertens Rep       Date:  2011-02       Impact factor: 5.369

4.  Association of DASH diet with cardiovascular risk factors in youth with diabetes mellitus: the SEARCH for Diabetes in Youth study.

Authors:  Angela D Liese; Andrey Bortsov; Anke L B Günther; Dana Dabelea; Kristi Reynolds; Debra A Standiford; Lenna Liu; Desmond E Williams; Elizabeth J Mayer-Davis; Ralph B D'Agostino; Ronny Bell; Santica Marcovina
Journal:  Circulation       Date:  2011-03-21       Impact factor: 29.690

Review 5.  Update on the metabolic syndrome: hypertension.

Authors:  Kristi Reynolds; Rachel P Wildman
Journal:  Curr Hypertens Rep       Date:  2009-04       Impact factor: 5.369

6.  The effect of DASH diet on pregnancy outcomes in gestational diabetes: a randomized controlled clinical trial.

Authors:  Z Asemi; M Samimi; Z Tabassi; A Esmaillzadeh
Journal:  Eur J Clin Nutr       Date:  2014-01-15       Impact factor: 4.016

Review 7.  Management of the metabolic syndrome and type 2 diabetes through lifestyle modification.

Authors:  Faidon Magkos; Mary Yannakoulia; Jean L Chan; Christos S Mantzoros
Journal:  Annu Rev Nutr       Date:  2009       Impact factor: 11.848

8.  Effects of the DASH diet on blood pressure in patients with and without metabolic syndrome: results from the DASH trial.

Authors:  Fadi Hikmat; L J Appel
Journal:  J Hum Hypertens       Date:  2013-09-26       Impact factor: 3.012

9.  A calorie-restriction diet supplemented with fish oil and high-protein powder is associated with reduced severity of metabolic syndrome in obese women.

Authors:  H-Y Su; H-C Lee; W-Y Cheng; S-Y Huang
Journal:  Eur J Clin Nutr       Date:  2014-09-24       Impact factor: 4.016

10.  A web-based nutrition program reduces health care costs in employees with cardiac risk factors: before and after cost analysis.

Authors:  Naomi Sacks; Howard Cabral; Lewis E Kazis; Kelli M Jarrett; Delia Vetter; Russell Richmond; Thomas J Moore
Journal:  J Med Internet Res       Date:  2009-10-23       Impact factor: 5.428

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.